C/EBPβ Promotes LPS-Induced IL-1β Transcription and Secretion in Alveolar Macrophages via NOD2 Signaling
Yalan Luo,Peng Ge,Haiyun Wen,Yibo Zhang,Jin Liu,Xuanchi Dong,Bowen Lan,Guixin Zhang,Qi Yang,Hailong Chen
DOI: https://doi.org/10.2147/jir.s377499
IF: 4.5
2022-09-11
Journal of Inflammation Research
Abstract:Yalan Luo, 1– 3, &ast Peng Ge, 1– 3, &ast Haiyun Wen, 1– 3, &ast Yibo Zhang, 1– 3 Jin Liu, 1, 3 Xuanchi Dong, 1, 3 Bowen Lan, 1, 3 Guixin Zhang, 1– 3 Qi Yang, 4 Hailong Chen 1– 3 1 Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China; 2 Institute (College) of Integrative Medicine, Dalian Medical University, Dalian, People's Republic of China; 3 Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China; 4 Department of Traditional Chinese Medicine, The Second Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China &astThese authors contributed equally to this work Correspondence: Qi Yang; Hailong Chen, Email ; Objective: C/EBPβ, a crucial transcription factor, regulates innate immunity and inflammatory responses. However, the role played by C/EBPβ in alveolar macrophage (AM) inflammatory responses remains unknown. This study aimed to investigate the role and mechanism of C/EBPβ in alveolar macrophages (AMs) from the transcriptional level and to search for natural compounds targeting C/EBPβ. Methods: Rat AMs were infected with Lv-sh-C/EBPβ and treated with LPS, and the expression levels of iNOS, TNF-α, IL-6, and IL-1β were measured by RT-qPCR, Western blotting, and ELISA. Mechanistically, transcriptome sequencing (RNA-seq) revealed changes in gene expression patterns in AMs after LPS stimulation and C/EBPβ knockdown. Functional enrichment analyses and rescue experiments identified and validated inflammation-associated cell signaling pathways regulated by C/EBPβ. Furthermore, virtual screening was used to search for natural compounds that inhibit C/EBPβ with the structure of helenalin as a reference. Results: Following stimulation with LPS, AMs exhibited an increased expression of C/EBPβ. C/EBPβ knockdown significantly decreased the expression levels of inflammatory mediators. A total of 374 differentially expressed genes (DEGs) were identified between LPS-stimulated C/EBPβ knockdown and negative control cells. The NOD-like receptor signaling may be a key target for C/EBPβ, according to functional enrichment analyses of the DEGs. Further experiments showed that the muramyl dipeptide (MDP, NOD2 agonist) reversed the downregulation of inflammatory mediators and the NF-κB pathway caused by the C/EBPβ knockdown. The virtual screening revealed that N-caffeoyltryptophan, orilotimod, and petasiphenone have comparable pharmacological properties to helenalin (a known C/EBPβ inhibitor) and demonstrate a great binding capacity to C/EBPβ. Conclusion: Ablation of C/EBPβ may attenuate LPS-induced inflammatory damage in AMs by inhibiting the NOD2 receptor signaling pathway. Three natural compounds, N-caffeoyltryptophan, orilotimod, and petasiphenone, may be potential C/EBPβ inhibitors. Graphical Keywords: C/EBPβ, alveolar macrophage, RNA-seq, NOD-like receptor signaling pathway, IL-1β, virtual screening Graphical Alveolar macrophages (AMs) are alveolar compartment resident phagocytes, constituting more than 90% of lung macrophages, with the ability to self-renew and serve as the first line of defense against extra-alveolar stimuli. 1 Under physiological conditions, AMs play a vital role in maintaining host defense and immune homeostasis in the lung by acting as sentinels to monitor and engulf foreign pathogens and senescent cells. 2 However, in response to stimulation by various pathogenic factors, AMs are excessively activated, which is thought to be the initiating factor of inflammatory damage in the lung. 3 Inflammation induction and recovery phases are accompanied by the explosive accumulation of macrophages in the lungs. They synthesize and secrete a broad series of inflammation-inducing mediators, including the interleukins (ILs) family (IL-1β, IL-12, IL-23), TNF-α, chemokine family, inducible nitric oxide synthase (iNOS), which act as chemoattractants for invading cells (polymorphonuclear leukocytes), triggering an inflammatory cascade and a pro-inflammatory environment, causing inflammatory tissue damage. 4 Inflammatory mediators are effectors and magnifiers of macrophage-induced tissue injury, and inhibiting their expression and secretion is a powerful measure to attenuate organ damage. Unfortunately, transcriptional regulatory networks of inflammatory mediator expression in AMs have not yet been fully elucidated. CCAAT enhancer binding protein β (C/EBPβ) is -Abstract Truncated-
immunology